NeuraLed

NeuraLed develops non-invasive red and near-infrared light therapy technology designed to support brain health, mental clarity, cognitive performance, relaxation and overall well-being. Its flagship NeuraLed Axion combines precision photobiomodulation, guided protocols and scientific expertise for at-home and practitioner-supported use.

Visit neuraled.co ↗

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

NeuraLed has advanced its non-invasive brain wellness platform centered around its flagship flagship device, the NeuraLed Axion. The company integrates precision photobiomodulation technology with guided protocols to serve both at-home wellness users and healthcare practitioners. Public visibility centers on its comprehensive digital footprint detailing triple-wavelength light therapy, QEEG-informed protocol support, and structured consumer offerings such as satisfaction guarantees and device consultations.

Market position

NeuraLed operates within the emerging neurotechnology and medical device landscape, targeting cognitive performance, brain health, and mental wellness. Positioning itself at the intersection of consumer wellness and professional care, the company differentiates from standard relaxation tools by offering practitioner-supported training, customizable protocols, and high-spec hardware architectures—such as its 330-LED configuration and 21 independent stimulation zones. It competes in the broader photobiomodulation and light therapy sector alongside specialized neuro-stimulation and cognitive enhancement hardware developers.

Growth & opportunities

NeuraLed is operating as an emerging player focused on scaling its core technology and distribution channels across consumer and clinical segments. The company has concentrated its growth efforts on refining its hardware platform—specifically the NeuraLed Axion and NeuraSync technology—while establishing a service and support model that accommodates both individual users and clinical practitioners.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes NeuraLed distinct

reccy insights

What makes NeuraLed distinct

01Focuses on making non-invasive, science-based brain wellness support accessible for home use.
02NeuraLed Axion combines triple-wavelength photobiomodulation, 21 stimulation zones and precision light dosimetry.
03Offers pre-configured and customizable protocols through an integrated touchscreen tablet and wireless connectivity.
04Combines consumer device access with practitioner training, QEEG-informed protocol design and ongoing scientific support.
05Provides a 90-day satisfaction guarantee, one-year warranty, free shipping and a device consultation.

Technology & products

NeuraLed Axion
A brain photobiomodulation helmet combining triple-wavelength light therapy, 21 stimulation zones, and precision light dosimetry for at-home and practitioner-supported use.

NeuraLed Axion brain photobiomodulation helmet
NeuraSync Technology with 21 application modules
Triple-wavelength light therapy using 660nm, 810nm and 1070nm wavelengths
330-LED architecture with high-power and ultra-high-power LED modules
Precision light dosimetry with adjustable intensity from 10% to 100%
21 independent activation zones

In the Cortex

NeuraLed Launches Photobiomodulation Device at Paris EventNeuraLed on LinkedIn · Mar 19, 2026

About NeuraLed

Products: NeuraLed Axion
Focus areas: Brain health, pbm, light therapy, mental wellness, cognitive performance, neurotechnology, at home wellness, practitioner programs
Headquarters: Paris, France